---
provider: perplexity
model: sonar-pro
cached: true
start_time: '2025-11-03T21:38:36.095347'
end_time: '2025-11-03T21:38:36.096594'
duration_seconds: 0.0
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    reasoning_effort: low
    search_domain_filter: []
    return_citations: true
    temperature: 0.0
citation_count: 13
---

## Question

Research the LYPD2 (Q6UXB3) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.

## Output

The **LYPD2 (Q6UXB3) gene** encodes the Ly6/PLAUR domain-containing protein 2, a member of the LY6/uPAR superfamily, with evidence for cell surface localization and potential roles in cell activation and mucus regulation, but its precise molecular function and disease associations remain incompletely characterized[3][5][8][9][11].

---

### 1. Key Concepts and Definitions

- **Gene Name:** LYPD2 (Ly6/PLAUR domain-containing protein 2)
- **Aliases:** LYPDC2
- **UniProt ID:** Q6UXB3
- **Chromosomal Location:** 8q24.3[1][3]
- **Protein Family:** LY6/uPAR superfamily

---

### 2. Molecular Function

- **Predicted Function:** The molecular function of LYPD2 is currently *unknown* according to Gene Ontology annotations[10]. However, it is predicted to be involved in **protein binding** (GO:0005515)[11].
- **Protein Domain:** Contains a single **Ly6/uPAR (LU) domain**, characterized by 6–10 conserved cysteine residues forming a three-finger structural motif, typical of the LY6/uPAR family[1][5].
- **GPI-Anchored Glycoprotein:** LYPD2 is a **glycosylphosphatidylinositol (GPI)-anchored** cell surface glycoprotein, suggesting a role in cell signaling or adhesion[5].

---

### 3. Biological Processes

- **Unknown Biological Process:** No specific biological process has been experimentally confirmed for LYPD2[10].
- **Hypothesized Role:** Based on expression patterns, LYPD2 may be involved in **regulation of mucus production**, particularly in goblet cells and secretory epithelia[8].
- **Related Pathways:** Associated with **metabolism of proteins** and **post-translational modification: synthesis of GPI-anchored proteins**[3].

---

### 4. Cellular Localization

- **Extracellular Region:** Predicted to be located in the **extracellular region**[3][11].
- **Plasma Membrane:** Also predicted to localize to the **plasma membrane** as a GPI-anchored protein[3][5][11].
- **Secretory Epithelia:** Expression is noted in goblet cells and other secretory epithelia, supporting extracellular and membrane localization[8].

---

### 5. Protein Domains

- **Ly6/uPAR (LU) Domain:** The protein contains one copy of the LU domain, which is about 100 amino acids long and features 10 conserved cysteines with a defined disulfide-bonding pattern[1][5].
- **Three-Finger Motif:** The LU domain forms a three-finger structural motif, similar to neurotoxins and other LY6 family proteins[1].

---

### 6. Known Interactions

- **Protein Binding:** LYPD2 is annotated with protein binding capability (GO:0005515)[11].
- **Paralog:** An important paralog is **SLURP1**, another LY6/uPAR family member involved in skin homeostasis and immune regulation[3].
- **No Direct Interaction Partners:** No experimentally validated protein-protein interactions are currently reported for LYPD2.

---

### 7. Disease Associations

- **Mal De Meleda:** LYPD2 is listed as associated with **Mal De Meleda**, a rare skin disorder, though the nature of this association is not well defined and may be based on pathway or paralog relationships rather than direct causality[3].
- **Cancer Biomarker Potential:** The LY6 gene family, including LYPD2, is frequently amplified in cancers (e.g., uterine corpus endometrial carcinoma, UCEC), and upregulation of LY6 genes is associated with poor prognosis and immune escape in several tumor types[1]. However, direct evidence for LYPD2’s role in cancer is limited compared to other LY6 family members.
- **No Confirmed Pathogenic Mutations:** No pathogenic mutations or direct disease mechanisms have been reported for LYPD2 as of 2024.

---

### 8. Recent Developments and Expert Analysis (2023–2024)

- **Bioinformatic Analyses:** Recent transcriptomic and bioinformatic studies highlight the upregulation of LY6 family genes in cancer, but LYPD2’s specific contribution remains unclear[1].
- **Functional Hypotheses:** Expression in secretory epithelia suggests a possible role in mucus production and epithelial homeostasis, but this is based on expression data rather than functional assays[8].
- **Immunotherapy Targeting:** High surface expression of LY6 proteins in tumors makes them potential targets for immunotherapy, though LYPD2-specific strategies have not been developed[1].

---

### 9. Summary Table

| Feature                | Details                                                                 |
|------------------------|------------------------------------------------------------------------|
| **Gene Symbol**        | LYPD2 (LYPDC2)                                                         |
| **UniProt ID**         | Q6UXB3                                                                  |
| **Protein Domain**     | Ly6/uPAR (LU) domain; three-finger motif                               |
| **Cellular Localization** | Extracellular region, plasma membrane (GPI-anchored)                  |
| **Molecular Function** | Protein binding (predicted); function largely unknown                  |
| **Biological Process** | Unknown; hypothesized role in mucus production                         |
| **Known Interactions** | Paralog: SLURP1; no direct partners reported                           |
| **Disease Associations** | Mal De Meleda (uncertain); cancer biomarker potential (family-wide)    |
| **Recent Research**    | Expression in secretory epithelia; upregulation in some cancers        |

---

### 10. Authoritative Sources and URLs

- [GeneCards: LYPD2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LYPD2) (2025)[3]
- [UniProt: Q6UXB3](https://www.uniprot.org/uniprotkb/Q6UXB3/entry) (2024)[9]
- [PMC: Human LY6 gene family](https://pmc.ncbi.nlm.nih.gov/articles/PMC10159366/) (2023)[1]
- [Genomics 2 Proteins Portal: LYPD2](https://g2p.broadinstitute.org/gene/LYPD2) (2024)[7]
- [BioGPS: LYPD2](http://biogps.org/gene/137797/) (2024)[11]
- [Genular: LYPD2](https://genular.atomic-lab.org/details-gene/137797?contexts%5B%5D=MONDO0008433) (2024)[8]

---

**In summary:** LYPD2 is a GPI-anchored cell surface protein with a conserved LU domain, likely involved in protein binding and possibly mucus regulation, but its precise molecular function, interaction partners, and disease mechanisms remain to be elucidated. It is part of a gene family with emerging relevance in cancer biology and epithelial physiology[1][3][5][8][11].

## Citations

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10159366/
2. https://figshare.mq.edu.au/articles/thesis/Sputum_protein_N-glycosylation_in_cystic_fibrosis_a_sweet_response_to_bacterial_colonisation/19428413/1/files/34520390.pdf
3. https://www.genecards.org/cgi-bin/carddisp.pl?gene=LYPD2
4. https://patents.google.com/patent/US20230357754A1/en
5. https://gnpbio.com/index.php/products/2255/10/expression-ready-gene-clones/human-lypd2-lypdc2-gene-full-length-cdna-in-lentivector-endotoxin-free-dna-detail
6. https://ciencia.ucp.pt/files/89292854/Thesis_-_UBI_final_digital_signed.pdf
7. https://g2p.broadinstitute.org/gene/LYPD2
8. https://genular.atomic-lab.org/details-gene/137797?contexts%5B%5D=MONDO0008433
9. https://www.uniprot.org/uniprotkb/Q6UXB3/entry
10. https://functionome.geneontology.org/gene/UniProtKB:Q6UXB3
11. http://biogps.org/gene/137797/
12. https://glycosmos.org/glycoproteins/Q6UXB3
13. Gene Ontology annotations[10]